Show simple item record

dc.contributor.author Sarkadi, Hunor
dc.contributor.author Berczi, Viktor
dc.contributor.author Kollar, Attila
dc.contributor.author Kiss D
dc.contributor.author Jakabfi P
dc.contributor.author Végh, Eszter Mária
dc.contributor.author Nemes, Balázs
dc.contributor.author Merkely, Béla Péter
dc.contributor.author Hüttl, Kálmán
dc.contributor.author Dósa, Edit
dc.date.accessioned 2016-04-08T10:04:02Z
dc.date.available 2016-04-08T10:04:02Z
dc.date.issued 2015
dc.identifier.citation pagination=199-204; journalVolume=20; journalIssueNumber=1; journalTitle=EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/2911
dc.identifier.uri doi:10.1016/j.ejvs.2014.12.004
dc.description.abstract OBJECTIVE: To determine the safety, clinical outcome, and fracture rate of femoropopliteal interventions using 4F stents. METHODS: Between January 2010 and December 2011, 112 symptomatic patients were treated by stent implantation. Ten patients were lost to follow up; therefore, 102 patients (62 men; mean age 66.4 +/- 10.1 years) were retrospectively analyzed. The indication for femoropopliteal revascularization was severe claudication (Rutherford-Becker score = 3) in 63 (62%) patients and chronic critical limb ischemia (Rutherford-Becker score = 4-6) in 39 (38%). Follow up included palpation of peripheral pulses and measurement of ankle brachial index. In patients with suspected in-stent restenosis duplex ultrasonography was performed. In 2013, patients were asked to return for a fluoroscopic examination of the stents. RESULTS: 114 lesions (Trans-Atlantic InterSociety Consensus-C and D, n = 45) were treated with 119 stents (Astron Pulsar, n = 42; Pulsar-18, n = 77). Lesions were long (>/=100 mm) in 49 cases and heavily calcified in 35. Stents were long (>/=120 mm) in 46 cases. Ten stents were partially overlapped. The technical and clinical success rates were 100%. Two puncture related complications were noted, neither of which required surgical repair. Eleven patients died (myocardial infarction, n = 4; stroke, n = 2; cancer, n = 5) and nine patients underwent major amputation (above knee, n = 4). The primary patency rate was 83% at 6 months and 80% at 12 months. The primary assisted patency rate was 97% at 6 months and 94% at 12 months. The secondary patency rate was 86% at 6 months and 85% at 12 months. The prevalence of fractures was 26% (type III and IV, 10%) after an average follow up of 25 months. CONCLUSION: Femoropopliteal stenting using a 4F compatible delivery system can be accomplished with a low complication rate, acceptable fracture rate, and with similar 12 month patency and revascularization rates as their 6F counterparts.
dc.relation.ispartof urn:issn:1078-5884
dc.title Safety, Clinical Outcome, and Fracture Rate of Femoropopliteal Stenting Using a 4F Compatible Delivery System.
dc.type Journal Article
dc.date.updated 2015-11-30T11:53:19Z
dc.language.rfc3066 en
dc.identifier.mtmt 2822386
dc.identifier.wos 000350526400017
dc.identifier.pubmed 25579877
dc.contributor.department SE/AOK/K/Városmajori Szív- és Érgyógyászati Klinika
dc.contributor.department SE/AOK/K/Radiológiai és Onkoterápiás Klinika
dc.contributor.institution Semmelweis Egyetem


Files in this item

xmlui.dri2xhtml.METS-1.0.onlyFromAllowedIP

View/Open

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account